Fusion proteins, understood as those created by joining two or more genes that originally encoded independent proteins, have numerous applications in biotechnology, from analytical methods to metabolic engineering. The use of fusion enzymes in biocatalysis may be even more interesting due to the physical connection of enzymes catalyzing successive reactions into covalently linked complexes. The proximity of the active sites of two enzymes in multi-enzyme complexes can make a significant contribution to the catalytic efficiency of the reaction. However, the physical proximity of the active sites does not guarantee this result. Other aspects, such as the nature and length of the linker used for the fusion or the order in which the enzymes are fused, must be considered and optimized to achieve the expected increase in catalytic efficiency. In this review, we will relate the new advances in the design, creation, and use of fused enzymes with those achieved in biocatalysis over the past 20 years. Thus, we will discuss some examples of genetically fused enzymes and their application in carbon‑carbon bond formation and oxidative reactions, generation of chiral amines, synthesis of carbohydrates, biodegradation of plant biomass and plastics, and in the preparation of other high-value products.
Sulfation of chitosan makes this polymer a closer mimic of heparins and heparan sulfates, giving rise to the so called heparanized chitosan, that exert their biological activities through their capacity to interact with a range of biological targets.
Controlling chondroitin sulfates (CSs) biological functions to exploit their interesting potential biomedical applications requires a comprehensive understanding of how the specific sulfate distribution along the polysaccharide backbone can impact in their biological activities, a still challenging issue. To this aim, herein, we have applied an “holistic approach” recently developed by us to look globally how a specific sulfate distribution within CS disaccharide epitopes can direct the binding of these polysaccharides to growth factors. To do this, we have analyzed several polysaccharides of marine origin and semi-synthetic polysaccharides, the latter to isolate the structure-activity relationships of their rare, and even unnatural, sulfated disaccharide epitopes. SPR studies revealed that all the tested polysaccharides bind to FGF-2 (with exception of CS-8, CS-12 and CS-13) according to a model in which the CSs first form a weak complex with the protein, which is followed by maturation to tight binding with kD ranging affinities from ~1.31 μM to 130 μM for the first step and from ~3.88 μM to 1.8 nM for the second one. These binding capacities are, interestingly, related with the surface charge of the 3D-structure that is modulated by the particular sulfate distribution within the disaccharide repeating-units.
This study characterizes a novel polyphosphate kinase from Burkholderia cenocepacia (BcPPK2-III), an enzyme with potential applications in ATP regeneration processes. Bioinformatic and structural analyses confirmed the presence of conserved motifs characteristic of PPK2 enzymes, including Walker A and B motifs, and the subclass-specific residue E137. Molecular docking simulations showed AMP had the highest binding affinity (−7.0 kcal/mol), followed by ADP (−6.5 kcal/mol), with ATP having the lowest affinity (−6.3 kcal/mol). It was overexpressed in Escherichia coli, after purification enzymatic activity assays revealed that BcPPK2-III needed divalent cations (Mg2⁺, Mn2⁺, Co2⁺) as cofactors to be active. Functional assays revealed its ability to synthesize ATP from AMP through a stepwise phosphorylation mechanism, forming ADP as an intermediate, achieving 70% ATP conversion (TTN 4354.7) after 24 h. Kinetic studies indicated cooperative behavior and substrate preference, with AMP phosphorylation to ADP being the most efficient step. The enzyme demonstrated high thermostability (T50 = 62 °C) and a broad pH stability range (pH 6.0–9.0), making it suitable for diverse biocatalytic applications. The study highlights BcPPK2-III as a robust and versatile candidate for cost-effective ATP regeneration, offering advantages in industrial processes requiring stoichiometric amounts of ATP.
The elevated concentration of vitamin B12 in blood has important diagnostic implications since it is associated with different pathologies such as liver and kidney diseases and solid tumours. However, the presence of immune complexed forms of this vitamin (Ig-B12), which have no pathological implications, significantly alters its diagnostic utility because of the overestimation of B12 levels. Thus, developing efficient and selective clinical methodologies for separating Ig-B12 complexes in human serum is crucial to ensure accurate diagnosis of elevated B12 levels and avoid artificial "enrichment" of medically insignificant vitamin forms. In this work, we present a new method based on the miniaturisation of the size-exclusion chromatography (SEC) gold-standard technique, capable of easily separating the Ig-B12 complexes from non-complexed vitamins (free-B12). A compact system of size-exclusion fractionation (SEF) columns has been designed, developed and tested to separate Ig-B12 and free-B12 resourcefully by rapid gel filtration. These columns are based on centrifugal filtration through a cross-linked dextran Sephadex G-100 resin. The SEF method was validated with sera from 30 patients, showing similar behaviour to the reference SEC technique for Ig-B12 detection (Pearson's coefficient 0.937, 90 % agreement). Furthermore, SEF was superior to polyethylene glycol (PEG) precipitation (Pearson's coefficient 0.769, 80 % agreement), the most utilised and standardised technique in clinical, both in correlation and concordance at a quantitative level. SEF columns allow the rapid and selective separation of Ig-B12 from free vitamin B12. This technique permits mimicking the gold-standard SEC technique but on a smaller scale, both in size and time, making it applicable in any clinical laboratory. The effective quantification of free-B12 allows the unadulterated diagnosis of the vitamin B12 concentration in blood serum.